Enjoy complimentary customisation on priority with our Enterprise License!
The coronary artery bypass grafting market size is estimated to grow by USD 30.3 million at a CAGR of 4.49% between 2023 and 2028. The Coronary Artery Bypass Grafting (CABG) market is witnessing significant growth due to the increasing prevalence of Coronary Artery Diseases (CAD) and the rising geriatric population. CAD is a major cause of mortality and morbidity worldwide, and the number of cases is projected to increase as the population ages. Additionally, the availability of alternatives such as Percutaneous Coronary Interventions (PCI) and Drug-Eluting Stents (DES) has increased competition in the market. However, the superior long-term outcomes of CABG compared to PCI and DES in certain patient populations continue to drive demand for the procedure. Furthermore, advancements in surgical techniques, such as Off-Pump Coronary Artery Bypass Grafting (OPCABG), have reduced the risk of complications associated with traditional CABG procedures. In conclusion, the CABG market is expected to grow steadily due to the increasing burden of CAD, an aging population, and the continued use of CABG as a preferred treatment option for certain patient populations.
For More Highlights About this Report, Request Free Sample
The market is primarily driven by the increasing prevalence of coronary artery disease (CAD) and acute coronary syndromes (ACS) such as strokes and myocardial infarction. The geriatric population is a significant contributor to the market growth due to the higher incidence of cardiovascular diseases (CVD) and chronic disorders like hypertension, myocardial injury, and myocardial infarction. Reimbursement initiatives and technological advancements in minimally invasive procedures, such as percutaneous coronary interventions (PCI) and catheter-based interventions, are propelling the market forward. Heart-lung machines and cardiopulmonary bypass devices are essential equipment in CABG surgeries. Minimally invasive procedures like off-pump CABG have gained popularity due to their reduced complications and faster recovery time. Drug eluting stents and PCI are alternative treatments for CAD. The Cleveland Clinic and other leading healthcare institutions are emphasizing the importance of early intervention and optimal patient care in managing CAD and other cardiovascular conditions. Overall, the CABG market is expected to grow steadily in the coming years due to the increasing burden of cardiovascular diseases and advancements in medical equipment and procedures. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Increasing prevalence of CVDs is notably driving market growth. Coronary Artery Bypass Grafting (CABG) is a surgical procedure performed to improve blood flow to the heart by bypassing blocked or narrowed coronary arteries. The primary indication for CABG is coronary artery disease (CAD), a condition characterized by the buildup of plaque in the arteries supplying blood to the heart.
Furthermore, risk factors for CAD include an unhealthy lifestyle, aging population, consumption of saturated and transfats, tobacco use, hypertension, diabetes, obesity, and physical inactivity. According to the Global Burden of Disease (GBD) study, cardiovascular diseases (CVDs), which include CAD, are the leading cause of death and disability worldwide. The GBD used various data sources to estimate the incidence, prevalence, and mortality of CVDs in 204 countries and territories from 1990 to 2019. The increasing patient base due to the rising prevalence of CVDs is expected to drive the growth of the CABG market. Thus, such factors are driving the growth of the market during the forecast period.
Increasing geriatric population is the key trend in the market. The global patient base for Coronary Artery Bypass Grafting (CABG) is expanding due to the increasing geriatric population, a demographic group with a higher risk of heart attacks and cardiac blockages. According to the United Nations (UN), the worldwide geriatric population (65 years and above) was 702.9 million in 2019 and is projected to reach 727 million in 2020.
Furthermore, in India, the geriatric population is expected to increase by 41% over the next decade, reaching 194 million in 2031. The aging population's susceptibility to cardiovascular diseases necessitates the growth of the CABG market. CABG is a surgical procedure used to improve blood flow to the heart by bypassing blocked or narrowed coronary arteries. This intervention is a critical treatment for individuals experiencing heart attacks or those at risk of having one. Thus, such trends will shape the growth of the market during the forecast period.
Availability of alternatives is the major challenge that affects the growth of the market. The market expansion is influenced by the increasing patient base suffering from coronary artery diseases, such as angina pectoris and heart attacks. However, the availability of alternative treatments poses a significant challenge to the market growth. These alternatives include heart repair and replacement devices, commissurotomy, percutaneous balloon mitral valvuloplasty, and vitamin D medications.
Furthermore, heart repair and replacement devices are utilized to address valvular heart diseases, including valve stenosis and regurgitation. Vitamin D3 medications, such as cholecalciferol, aid in the restoration of damaged cardiovascular epithelial cells, while blood thinners like aspirin help prevent blood clots, potentially reducing the need for CABG procedures. These alternatives limit the market's growth potential during the forecast period. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company offers coronary artery bypass grafting products under the brand name of Graftmaster RX.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth by the on-pump segment will be significant during the forecast period. The market encompasses medical equipment utilized in addressing coronary artery disease (CAD), acute coronary syndrome (ACS), and strokes, particularly in the geriatric population. This market caters to cardiovascular indications such as atrial fibrillation, diabetes, obesity, and hypertension, which contribute to myocardial injury, myocardial infarction, and chronic disorders.
Get a glance at the market share of various regions Download the PDF Sample
The on-pump segment. accounted for USD 46.80 million in 2018. Minimally invasive procedures, including percutaneous coronary interventions (PCI), and surgical techniques employ graft materials to bypass obstructed arteries. Key players in this field include Cleveland Clinic and healthcare providers in developing regions, focusing on cardiovascular health awareness and personalized treatment plans. Regulatory requirements and approval processes for medical devices and surgical procedures necessitate adherence to stringent standards, while healthcare budget constraints influence the selection of graft materials and treatment plans. Cardiovascular diseases, stemming from sedentary lifestyles and poor dietary habits, fuel market growth. Technological advancements in drug eluting stents, catheter-based interventions, and surgical techniques continue to shape the landscape of the CABG market.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The market encompasses medical equipment designed to address coronary artery disease (CAD), a leading cause of acute coronary syndrome (ACS) and strokes, particularly among the geriatric population. Minimally invasive procedures, such as percutaneous coronary interventions (PCI), including drug eluting stents and catheter-based interventions, are increasingly preferred for treating cardiovascular indications like atrial fibrillation, diabetes, obesity, and hypertension. Myocardial injury, myocardial infarction, and chronic disorders like chronic obstructive pulmonary disease (COPD) also necessitate CABG surgeries. Regulatory requirements and approval processes for medical devices and surgical procedures continue to evolve, impacting healthcare budget constraints and treatment plans. Eligible patients undergo graft selection based on individual needs, considering factors like surgical techniques, graft materials, and healthcare providers' expertise. Developing regions and cardiovascular health awareness campaigns are driving market growth, with personalized medicine and treatment plans becoming increasingly important. Sedentary lifestyles, poor dietary habits, and an aging population further fuel the demand for CABG procedures. Cleveland Clinic and other leading healthcare institutions are at the forefront of advancing CABG technology and techniques.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million " for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
3D Cardiac Mapping Systems Market: Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, China, UK, Japan - Size and Forecast
Vascular Grafts Market: Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Canada, China - Size and Forecast
Heart-lung Machines Market: by End-user, Application, and Geography - Forecast and Analysis
The market is witnessing significant growth due to the rising prevalence of cardiovascular diseases, including coronary artery disease, acute coronary syndrome, strokes, and chronic disorders such as diabetes, obesity, hypertension, and myocardial injury. The geriatric population is particularly vulnerable, as they are more prone to these conditions. CABG is a surgical procedure used to treat cardiovascular diseases by bypassing blocked or narrowed coronary arteries. Minimally invasive procedures, such as percutaneous coronary interventions (PCI), and catheter-based interventions, including drug-eluting stents, are also gaining popularity. Cleveland Clinic and other healthcare providers are emphasizing the importance of eligible patients undergoing CABG based on regulatory requirements and approval processes. Surgical grafts and devices play a crucial role in treating coronary heart disease and managing heart attack by enhancing the effectiveness of interventions performed with a heart-lung machine.
Furthermore, the market is driven by the increasing number of surgeries, cardiovascular diseases, and sedentary lifestyles, poor dietary habits, and aging population. The development of advanced graft materials and surgical techniques is also contributing to the growth of the market. Developing regions are expected to witness significant growth due to increasing healthcare budget constraints and cardiovascular health awareness. Personalized medicine and treatment plans are also playing a crucial role in graft selection for individual patients. Off pump CABG technology and advanced cardiopulmonary bypass device are transforming coronary artery bypass operations and heart valve replacement surgery, reducing the risk of complications such as stroke and improving outcomes for patients with cardiovascular disease through catheter based interventions.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
141 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.49% |
|
Market growth 2024-2028 |
USD 30.3 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
4.21 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 37% |
|
Key countries |
US, China, Russia, Canada, and India |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, Aesculap Inc., AtriCure Inc., Aruga Technologies, Bentley InnoMed GmbH, BIOTRONIK SE and Co. KG, Boston Scientific Corp., Cook Group Inc., Cryolife Inc., Gebruder Martin GmbH and Co. KG, Genesee BioMedical Inc., Getinge AB, Johnson and Johnson Services Inc., KARL STORZ SE and Co. KG, Medtronic Plc, Saphena Medical Inc., Scanlan International, Stryker Corp., Teleflex Inc., Terumo Corp., and VasoPrep Surgical |
|
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.